Previous 10 | Next 10 |
home / stock / cybn:cc / cybn:cc news
Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics ™ ” is pleased to announce that Doug Drysdale, Cybin’...
New research has found that ibogaine blocks some of the abuse-related effects of alcohol in mice. Ibogaine is a natural product extracted from the Tabernanthe iboga plant. It is commonly used during religious ceremonies in the form of tea and is extracted from the plant’s root, ba...
Cybin-sponsored study will use Kernel Flow, Kernel’s quantitative neuroimaging. Company hopes to learn more about impact ketamine has on brain activity, overall mental well-being. Study results may lead to future studies supporting CYBN’s mission to develop psychedelics ...
New research has discovered that the time at which an individual consumes food may impact their mental health. Focusing on what you eat is important for your overall health, but did you know that paying some attention to when you eat may also be good for your mental health? Research has ...
Cybin (NYSE American: CYBN) (NEO: CYBN) , a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that Adelia Therapeutics, a wholly controlled subsidiary of Cybin, has achieved the milestone identified as Year 1, Q2 (iv) as conte...
Interest in psychedelic substances has grown significantly these last couple of years as studies unearth more evidence on their benefits and numerous uses. That interest isn’t just confined to uses and benefits; attention has also been paid to psychedelic media. If you’re inter...
Cybin (NYSE American: CYBN) (NEO: CYBN) , a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that the first visit has been conducted in a Cybin-sponsored feasibility study. The study will focus on evaluating Kernel’s q...
Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics TM ”, today announced that the first study visit has been conducted in a Cybin-sponsored feasibility ...
Last week, the city council of Hazel Park, Michigan, moved to decriminalize psychedelic substances , including ibogaine and psilocybin. Before the city council unanimously passed the measure, the measure’s sponsor, Councilmember Luke Londo, revealed that he’d personally used p...
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – March 29, 2022 – Mental health cases are continuing to rise and are taking a serious toll on the healthcare system. Luckily, psychedelics like DMT, psilocybin, MDMA, and LSD are bein...
News, Short Squeeze, Breakout and More Instantly...
CYBIN INC. Company Name:
CYBN:CC Stock Symbol:
AQNC Market:
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options for mental-health disorders, is reporting “a swell” of insider purchases followi...
Miami, Florida--(Newsfile Corp. - July 8, 2024) - Fast-moving sectors need equally fast-moving companies, a box that Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) checks, supported by a June 26th update on progress made in fiscal 2024 ending on March 31st. In its presser , Cybin highlighted k...
Cybin (NYSE American: CYBN) (Cboe CA: CYBN) , a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options for mental-health disorders, is reporting its audited financial results for the fiscal year en...